Dr. Butowski on Real-Time Imaging of Nanoliposomal Irinotecan Injection

Video

Nicholas A. Butowski, MD, discusses an early-stage study of convection-enhanced delivery of nanoliposomal irinotecan with real-time imaging.

Nicholas A. Butowski, MD, director, Translational Research in Neuro-Oncology, University of California, San Francisco, discusses an early-stage study of convection-enhanced delivery of nanoliposomal irinotecan with real-time imaging. These findings were reported on at the 2015 Annual Meeting of the Society for Neuro-Oncology.

Imaging a patient during injection has two benefits: a physician can make sure the target is being hit and can also correct any problems that might arise. Prior studies have used convection-enhanced delivery, Butowski says, but have not paired it with real-time imaging.

In this phase I study, researchers sought out to prove safety of the method.

Butowski hopes to take the strategy to the next level, though, by enhancing the delivery and reducing cost.

<<<

View more from the 2015 SNO Meeting

Related Videos
Patrick I. Borgen, MD
Kari Hacker, MD, PhD, NYU Grossman School of Medicine
Janos L. Tanyi, MD, PhD, associate professor, Obstetrics and Gynecology, Hospital of the University of Pennsylvania
Reshma Lillaney Mahtani, DO
Christian Marth, MD, PhD, head, professor, Department of Obstetrics and Gynecology, Innsbruck Medical University
Mansoor Raza Mirza, MD, chief oncologist, Department of Oncology, Rigshospitalet, Copenhagen University Hospital
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine
Leslie M. Randall, MD, MAS, professor, division head, Department of Obstetrics and Gynecology – Gynecologic Oncology, Virginia Commonwealth University School of Medicine Obstetrics and Gynecology
Dimitrios Nasioudis, MD, fellow, Gynecologic Oncology, Perelman School of Medicine, the University of Pennsylvania
Sara Corvigno, MD, PhD, translational researcher, oncology, The University of Texas MD Anderson Cancer Center